Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0LC0Q
|
|||
| Drug Name |
Brincidofovir
|
|||
| Synonyms |
CMX001; CMX 001; Hexadecyloxypropyl-cidofovir; HDP-CDV; CMX-001; Hexadecyloxypropyl cidofovir
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Investigative | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C27H52N3O7P
|
|||
| Canonical SMILES |
CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(CN1C=CC(=NC1=O)N)CO)O
|
|||
| InChI |
1S/C27H52N3O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-35-20-16-21-37-38(33,34)24-36-25(23-31)22-30-18-17-26(28)29-27(30)32/h17-18,25,31H,2-16,19-24H2,1H3,(H,33,34)(H2,28,29,32)/t25-/m0/s1
|
|||
| InChIKey |
WXJFKKQWPMNTIM-VWLOTQADSA-N
|
|||
| CAS Number |
CAS 444805-28-1
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29. Br J Pharmacol. 2020 May 1;10.1111/bph.15094. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.